Crowdfunding Carries Antabio Across the Valley of Death
By Marie Powers
Wednesday, October 3, 2012
Antabio, a start-up focused on developing drugs to prevent and treat antibiotic-resistant bacterial infections, has exited what it believes is the first successful round of crowdfunding for a French biotech.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.